{"database": "openregs", "table": "federal_register", "rows": [["2021-05323", "Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability; Reopening of the Comment Period", "Notice", "The Food and Drug Administration (FDA or Agency) is reopening the comment period for the notice entitled \"Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability\" that appeared in the Federal Register of December 9, 2020. The Agency is taking this action to allow interested persons additional time to submit comments.", "2021-03-16", 2021, 3, "https://www.federalregister.gov/documents/2021/03/16/2021-05323/best-practices-in-developing-proprietary-names-for-human-nonprescription-drug-products-draft", "https://www.govinfo.gov/content/pkg/FR-2021-03-16/pdf/2021-05323.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA or Agency) is reopening the comment period for the notice entitled \"Best Practices in Developing Proprietary Names for Human Nonprescription Drug Products; Draft Guidance for Industry; Availability\" that appeared...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2021-05323"], "units": {}, "query_ms": 105.75744009111077, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}